Balance Disorders News and Research

RSS
A balance disorder is a disturbance that causes an individual to feel unsteady, giddy, woozy, or have a sensation of movement, spinning, or floating. An organ in our inner ear, the labyrinth, is an important part of our vestibular (balance) system. The labyrinth interacts with other systems in the body, such as the visual (eyes) and skeletal (bones and joints) systems, to maintain the body's position. These systems, along with the brain and the nervous system, can be the source of balance problems.
GenVec announces data from respiratory syncytial virus vaccine program

GenVec announces data from respiratory syncytial virus vaccine program

GenVec 2011 net loss decreases to $7.4 million

GenVec 2011 net loss decreases to $7.4 million

New UNC clinic to address individuals with Angelman Syndrome

New UNC clinic to address individuals with Angelman Syndrome

New way to awaken paternal Ube3a allele linked with Angelman syndrome

New way to awaken paternal Ube3a allele linked with Angelman syndrome

Neurorehabilitation journal reviews clinical advances in treatment of vestibular problems

Neurorehabilitation journal reviews clinical advances in treatment of vestibular problems

Positive new data from Otonomy's OTO-104 Phase 1b study on Meniere's disease

Positive new data from Otonomy's OTO-104 Phase 1b study on Meniere's disease

Scientists discover mechanism behind MRI-induced vertigo

Scientists discover mechanism behind MRI-induced vertigo

Seven research teams across the U.S. to develop new drugs for nervous system disorders

Seven research teams across the U.S. to develop new drugs for nervous system disorders

Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine

Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine

Positive results from Otonomy's OTO-104 Phase 1b study in Meniere's disease

Positive results from Otonomy's OTO-104 Phase 1b study in Meniere's disease

New discovery may improve cochlear implants for deafness

New discovery may improve cochlear implants for deafness

Encouraging GenVec RSV vaccine program data presented at International Respiratory Syncytial Virus Symposium

Encouraging GenVec RSV vaccine program data presented at International Respiratory Syncytial Virus Symposium

GenVec receives $244,479 grant under QTDP program

GenVec receives $244,479 grant under QTDP program

Cascade enters non-binding letter of intent to acquire AcuNetx

Cascade enters non-binding letter of intent to acquire AcuNetx

UW Medicine patient receives implantable device for vestibular problems

UW Medicine patient receives implantable device for vestibular problems

GenVec completes initial milestone in collaboration with Novartis

GenVec completes initial milestone in collaboration with Novartis

Otonomy announces closing of $38.5 million Series B financing

Otonomy announces closing of $38.5 million Series B financing

GenVec signs new agreement with Novartis for supply of services relating to development materials

GenVec signs new agreement with Novartis for supply of services relating to development materials

GenVec reports net loss of $4.2M for second-quarter 2010

GenVec reports net loss of $4.2M for second-quarter 2010

GenVec creates novel vectors for vaccine development

GenVec creates novel vectors for vaccine development

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.